Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia
about
Orexin receptors: pharmacology and therapeutic opportunitiesInsomnia pharmacotherapyPharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disordersMelatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.Ramelteon prior to a short evening nap impairs neurobehavioral performance for up to 12 hours after awakening.Melatonin and its receptors: a new class of sleep-promoting agents.Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem.Insomnia medication use and the probability of an accidental event in an older adult population.Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjectsTherapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.Effect of Placebo Conditions on Polysomnographic Parameters in Primary Insomnia: A Meta-Analysis.Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial.Pharmacological Treatment of Insomnia.Sleep in older adults: normative changes, sleep disorders, and treatment options.Mood disorders, circadian rhythms, melatonin and melatonin agonists.Critical appraisal of ramelteon in the treatment of insomnia.A review of ramelteon in the treatment of sleep disordersPharmacotherapy of insomnia with ramelteon: safety, efficacy and clinical applicationsRamelteon for insomnia symptoms in a community sample of adults with generalized anxiety disorder: an open label study.Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomniaEfficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomniaRamelteon for the treatment of insomnia in menopausal womenNew approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists.Ramelteon for Insomnia Related to Attention-Deficit/Hyperactivity Disorder (ADHD).Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.Therapies for insomnia and comorbid chronic obstructive pulmonary disease with a focus on ramelteon (rozerem).Impact of Alzheimer disease patients' sleep disturbances on their caregivers.
P2860
Q24597418-1BAE155B-237A-4755-A75F-52B11CA7D567Q24623757-FCDC10B7-03B5-49CB-A2AA-75659E3A816EQ33854026-85B3A4D3-4B55-422D-974D-4FD7E3D01C30Q34416921-998E1164-2149-4C49-922A-3A3E34907858Q34458240-877E7159-E3DC-4B4A-91AE-88CCDE8310E1Q34682298-20EEA198-8236-410B-89A7-E03935FD68BEQ35016391-5B97C737-BAC0-47EF-80C7-5358E9F6FFEFQ35026469-B70571FA-B812-48B3-85C0-456838CC53B6Q35214361-F9984B44-4980-405C-9C31-3A4D8680713DQ35276597-EAA49635-42AF-46B5-8F39-7676899BD725Q35615485-2A8BAE33-801A-4B72-985F-52A61D4C6A7FQ36018973-915DE83F-902F-429D-9550-1DD24DA5296AQ36251904-F441AB9B-B604-493F-8538-7D3306ADA81BQ36307859-7E5F83A9-3D1C-4244-9049-031822C4A7CCQ36748061-6A189448-52E0-4E4C-A2EB-38B16700D9D7Q36779840-6BBB5D7B-1650-43E5-B57C-DFE9D85CEB93Q36836767-623B2EB3-DCEC-44AC-B0A1-4B0B25792D8CQ36873916-83135F57-79B9-4864-AA0E-4AC2D342A2E9Q37086857-EAC68320-0551-43B2-ADC7-E38EF0BC0076Q37086861-93EABC64-1B84-47CB-935C-8E8C71242A4CQ37109731-0EA8A850-BE02-4574-B538-B8AD3675E4FCQ37157345-4854E306-2278-4CC7-B374-BC6CFAEA17E9Q37235719-BB1C8DE8-1569-4A39-9BB8-D95BF43E1B9AQ37299888-FEB7ADF4-1B9D-4073-9094-C6FCF13FBF85Q39044821-22D1FBCA-F67D-4F1E-B008-BD962C59ADA2Q41859050-1CA983AF-A237-42EF-996D-F06E6102A736Q47675160-7CFFC8EB-50F4-405E-B131-F3ED37736EE5
P2860
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia
@ast
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia
@en
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia
@nl
type
label
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia
@ast
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia
@en
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia
@nl
prefLabel
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia
@ast
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia
@en
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia
@nl
P2093
P2860
P1476
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia
@en
P2093
Gary Zammit
Jeffrey Zhang
Milton Erman
Sherry Wang-Weigand
Stephen Sainati
Thomas Roth
P2860
P304
P407
P577
2007-08-01T00:00:00Z